SCHEMBL19974138

SCHEMBL19974138

Cc1nc(NC(=O)C=CC(=O)O)sc1-c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
XIAP P98170 2/20 0.61
MEN1 O00255 8/20 0.54
KMT2A Q03164 8/20 0.54
RAB9A P51151 6/20 0.54
NPC1 O15118 4/20 0.54
CASP3 P42574 1/20 0.54
SENP8 Q96LD8 1/20 0.54
SENP7 Q9BQF6 1/20 0.54
SENP6 Q9GZR1 1/20 0.54
ALDH1A1 P00352 8/20 0.54
MAPT P10636 4/20 0.54
LMNA P02545 3/20 0.54
GAA P10253 2/20 0.54
TP53 P04637 1/20 0.54
NFKB1 P19838 1/20 0.54
NFKB2 Q00653 1/20 0.54
RELA Q04206 1/20 0.54
TSHR P16473 1/20 0.52
CLK1 P49759 1/20 0.52
PIK3CD O00329 4/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19974136 1.00 XIAP (0.61) XIAPMEN1KMT2ARAB9ANPC1
SCHEMBL19981509 0.85 ALDH1A1 (0.55) XIAPMEN1KMT2ARAB9ANPC1
SCHEMBL19974430 0.83 ALDH1A1 (0.47) XIAPMEN1KMT2ARAB9AALDH1A1
SCHEMBL19974431 0.83 ALDH1A1 (0.47) XIAPMEN1KMT2ARAB9AALDH1A1
SCHEMBL12992093 0.81 PIK3CG (0.74) XIAPMEN1KMT2ARAB9ANPC1
SCHEMBL19974188 0.78 SMN1; SMN2 (0.56) MEN1KMT2ARAB9ANPC1ALDH1A1
SCHEMBL19974189 0.78 SMN1; SMN2 (0.56) MEN1KMT2ARAB9ANPC1ALDH1A1
SCHEMBL27597050 0.76 PIK3CA (0.68) XIAPMEN1KMT2ARAB9ANPC1
SCHEMBL2342623 0.75 NPC1 (0.60) XIAPMEN1KMT2ARAB9ANPC1
SCHEMBL23647317 0.73 LMNA (0.50) XIAPMEN1KMT2ARAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3512602-B1 INHIBITORS OF HEAT SHOCK FACTORS (HSF) AND USES THEREOF HSF PHARMACEUTICALS (CH) 2024-03-27 EP disclosed
US-11597708-B2 Inhibitors of heat shock factors and uses thereof HSF PHARMACEUTICALS SA (CH) 2023-03-07 US disclosed
US-20210221778-A1 Inhibitors of heat shock factors and uses thereof HSF PHARMACEUTICALS SA (CH) 2021-07-22 US disclosed
EP-3512602-A2 INHIBITORS OF HEAT SHOCK FACTORS AND USES THEREOF HSF Pharmaceuticals (CH) 2019-07-24 EP disclosed
WO-2018050656-A2 INHIBITORS OF HEAT SHOCK FACTORS AND USES THEREOF HSF PHARMACEUTICALS (CH) 2018-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11597708-B2 Inhibitors of heat shock factors and uses thereof HSF1, HSP90AB2P, HSP90AB1 XIAP 363/4885MEN1 4586/4885KMT2A 3452/4885
US-20210221778-A1 Inhibitors of heat shock factors and uses thereof HSF1, HSP90AB2P, HSP90AB1 XIAP 363/4885MEN1 4586/4885KMT2A 3452/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.